PubMed

Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes: a randomized trial.

Dawson J, Quinn T, Harrow C, Lees KR, Weir CJ, Cleland SJ, Walters MR.

Diabetes Care. 2009 Jan;32(1):135-7. Epub 2008 Oct 22.PMID: 18945924 [PubMed - in process]Related articlesFree article

Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes.

Nazir FS, Alem M, Small M, Connell JM, Lees KR, Walters MR, Cleland SJ.

Diabet Med. 2006 Apr;23(4):398-402.PMID: 16620268 [PubMed - indexed for MEDLINE]Related articles

Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers.

Guthikonda S, Sinkey C, Barenz T, Haynes WG.

Circulation. 2003 Jan 28;107(3):416-21.PMID: 12551865 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial.

Dawson J, Quinn TJ, Harrow C, Lees KR, Walters MR.

Br J Clin Pharmacol. 2009 Nov;68(5):662-8.PMID: 19916990 [PubMed - in process]Related articles

Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study.

John S, Schlaich M, Langenfeld M, Weihprecht H, Schmitz G, Weidinger G, Schmieder RE.

Circulation. 1998 Jul 21;98(3):211-6.PMID: 9697820 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.

Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, Schuler G, Coats AJ, Anker SD, Hambrecht R.

Circulation. 2002 Jun 4;105(22):2619-24.PMID: 12045167 [PubMed - indexed for MEDLINE]Related articlesFree article

A dose-response study of nitric oxide synthase inhibition in different vascular beds in man.

Hjorth Lassen L, Klingenberg Iversen H, Olesen J.

Eur J Clin Pharmacol. 2003 Oct;59(7):499-505. Epub 2003 Sep 6.PMID: 13680036 [PubMed - indexed for MEDLINE]Related articles

Nitric oxide-dependent endothelial function is unaffected by allopurinol in hypercholesterolaemic subjects.

O'Driscoll JG, Green DJ, Rankin JM, Taylor RR.

Clin Exp Pharmacol Physiol. 1999 Oct;26(10):779-83.PMID: 10549401 [PubMed - indexed for MEDLINE]Related articles

Cerebral blood flow during inhibition of brain nitric oxide synthase activity in normal, hypertensive, and stroke-prone rats.

Izuta M, Clavier N, Kirsch JR, Traystman RJ.

Stroke. 1995 Jun;26(6):1079-85.PMID: 7539167 [PubMed - indexed for MEDLINE]Related articlesFree article

Systemic nitric oxide synthase inhibition increases insulin sensitivity in man.

Butler R, Morris AD, Struthers AD.

Clin Sci (Lond). 1998 Feb;94(2):175-80.PMID: 9536926 [PubMed - indexed for MEDLINE]Related articles

Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.

Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A.

Circulation. 1993 Jul;88(1):43-54.PMID: 8319355 [PubMed - indexed for MEDLINE]Related articles

Intracarotid infusion of the nitric oxide synthase inhibitor, L-NMMA, modestly decreases cerebral blood flow in human subjects.

Joshi S, Young WL, Duong DH, Ostapkovich ND, Aagaard BD, Hashimoto T, Pile-Spellman J.

Anesthesiology. 2000 Sep;93(3):699-707.PMID: 10969303 [PubMed - indexed for MEDLINE]Related articlesFree article

Nitric oxide activity in the atherosclerotic human coronary circulation.

Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO 3rd.

J Am Coll Cardiol. 1997 Feb;29(2):308-17.PMID: 9014982 [PubMed - indexed for MEDLINE]Related articles

AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans.

Bellien J, Iacob M, Eltchaninoff H, Bourkaib R, Thuillez C, Joannides R.

Clin Sci (Lond). 2007 Jun;112(7):393-401.PMID: 17125466 [PubMed - indexed for MEDLINE]Related articles

Haemodynamic effects of inhibition of nitric oxide synthase and of L-arginine at rest and during exercise.

Brett SE, Cockcroft JR, Mant TG, Ritter JM, Chowienczyk PJ.

J Hypertens. 1998 Apr;16(4):429-35.PMID: 9797188 [PubMed - indexed for MEDLINE]Related articles

Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis.

Shiode N, Morishima N, Nakayama K, Yamagata T, Matsuura H, Kajiyama G.

J Am Coll Cardiol. 1996 Feb;27(2):304-10.PMID: 8557898 [PubMed - indexed for MEDLINE]Related articles

The effect of antihypertensive therapy on responsiveness to local intra-arterial NG-monomethyl-L-arginine in patients with essential hypertension.

Lyons D, Webster J, Benjamin N.

J Hypertens. 1994 Sep;12(9):1047-52.PMID: 7852748 [PubMed - indexed for MEDLINE]Related articles

Role of nitric oxide in the airway response to exercise in healthy and asthmatic subjects.

De Gouw HW, Marshall-Partridge SJ, Van Der Veen H, Van Den Aardweg JG, Hiemstra PS, Sterk PJ.

J Appl Physiol. 2001 Feb;90(2):586-92.PMID: 11160057 [PubMed - indexed for MEDLINE]Related articlesFree article

Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.

Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO 3rd.

Circulation. 1995 Aug 1;92(3):320-6.PMID: 7634444 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of a nitric oxide synthase inhibitor in humans with septic shock.

Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P.

Cardiovasc Res. 1994 Jan;28(1):34-9.PMID: 7509259 [PubMed - indexed for MEDLINE]Related articles